Erica DeMarch, PT conducts a follow-up interview with us for another podcast episode
Every six minutes, someone will be diagnosed with Parkinson’s disease in the United States.
Erica DeMarch, a physical therapist specializing in neuro, vestibular, and balance rehabilitation, asked the same two questions to the six Parkinson’s experts she interviewed in April for her website www.stepandconnect.com.
The 6th and final podcast episode of this series is: Ask the Parkinson’s Expert - Take 6 for PD. The participants are Melissa McConaghy, Josepha Domingos, John Dean, Dr. Eric Rhoden, Dr. Becky Farley, Betsy Vierck, and Catherine Ross.
At this point, readers may choose to-
1) Click here to go directly to the podcast. Betsy and Cathy responded to the two queries at about 35:25 in this podcast.
2) Another option is to continue reading the summary below of the topics discussed in our interview before listening to the podcast.
SUMMARY
Tips to decrease the progression of Parkinson’s disease.
Read research articles and textbooks.
Build awareness of posture
Be informed of what can happen to your body and work against these symptoms.
Exercise is our new medicine.
Exercising with others who have Parkinson’s builds a support network of friends.
Exercise should be goal oriented. An example of a possible goal is to increase stamina for an upcoming vacation trip.
What new research are we following?
We are frustrated with the slow research process and slow FDA approval time, especially when a medication is in use in Europe, but not approved in the US.
Subcutaneous continuous delivery of dopamine or an agonist. This is approved in Europe, but not the US.
Click here to learn more about this method of medication delivery and watch a video discussion by Daniel E. Kremens, MD, JD, and Rajeev Kumar, MD. Continuous Subcutaneous Apomorphine Infusion in Development for OFF Episodes in Parkinson’s Disease. Neurology Live. Oct 13, 2020.
Exenatide is a medication approved for diabetes. It appears to stop the progression of Parkinson’s. The second clinical trial in the US has just been completed. The third clinical trial has begun in the UK. We continue to wait for results from the US trials.
Click here to read about this research. Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3) ClinicalTrials.gov
______________
Click here to view the Show Notes and listen to this sixth podcast episode in this series with our responses to Erica’s queries: Ask the Parkinson’s Expert – Take 6 for PD (May 04, 2023.)
Our response is about 35:25 in this podcast, but we invite you to listen to the full episode to hear the responses of the other experts.
If you missed our first podcast with Erica DeMarch, you can listen and read the summary. Click here.
Click here to listen to all six podcast episodes in the Parkinson’s Series: March 28, 2023-May 4, 2023
